{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T01:23:29Z","timestamp":1788053009289,"version":"build-2784847793"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.cbi.2025.111412","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T23:47:12Z","timestamp":1738712832000},"page":"111412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Subtype-selective effect and molecular regulation of celastrol and triptolide at human nicotinic acetylcholine receptors"],"prefix":"10.1016","volume":"408","author":[{"given":"Myungmi","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minsu","family":"Pyeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongyeon","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Duck","family":"Yeom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mee-Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gihyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0913-8578","authenticated-orcid":false,"given":"Junho H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2025.111412_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cbi.2025.111412_bib2","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2017.0174","article-title":"The nicotinic acetylcholine receptor: a typical 'allosteric machine'","volume":"373","author":"Changeux","year":"2018","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.cbi.2025.111412_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1146\/annurev.pharmtox.47.120505.105214","article-title":"Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system","volume":"47","author":"Dani","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2025.111412_bib4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.tips.2006.07.004","article-title":"Brain nicotinic acetylcholine receptors: native subtypes and their relevance","volume":"27","author":"Gotti","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2025.111412_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrn1298","article-title":"The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour","volume":"5","author":"Laviolette","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cbi.2025.111412_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/bs.irn.2015.07.001","article-title":"Neuronal nicotinic acetylcholine receptor structure and function and response to nicotine","volume":"124","author":"Dani","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.cbi.2025.111412_bib7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2741\/2695","article-title":"Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease","volume":"13","author":"Picciotto","year":"2008","journal-title":"Front. Biosci. : J. Vis. Literacy"},{"key":"10.1016\/j.cbi.2025.111412_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrd2927","article-title":"Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system","volume":"8","author":"Taly","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cbi.2025.111412_bib9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/aps.2009.37","article-title":"Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance","volume":"30","author":"Bencherif","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cbi.2025.111412_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10254-003-0005-1","article-title":"Nicotinic acetylcholine receptors: from structure to brain function","volume":"147","author":"Hogg","year":"2003","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111412_bib11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3181\/0712-MR-355","article-title":"Influence of neuronal nicotinic receptors over nicotine addiction and withdrawal","volume":"233","author":"De Biasi","year":"2008","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.cbi.2025.111412_bib12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bcp.2009.05.003","article-title":"Multiple roles for nicotine in Parkinson's disease","volume":"78","author":"Quik","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111412_bib13","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1523\/JNEUROSCI.22-20-08785.2002","article-title":"Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum","volume":"22","author":"Zoli","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2025.111412_bib14","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s11064-010-0185-4","article-title":"Antioxidant activity and protective effects of Tripterygium regelii extract on hydrogen peroxide-induced injury in human dopaminergic cells, SH-SY5Y","volume":"35","author":"Choi","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cbi.2025.111412_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/cns.12039","article-title":"Triptolide with potential medicinal value for diseases of the central nervous system","volume":"19","author":"Zheng","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.cbi.2025.111412_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1039\/c2np00088a","article-title":"Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms","volume":"29","author":"Zhou","year":"2012","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.cbi.2025.111412_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fmed.2017.00069","article-title":"Celastrol: a spectrum of treatment opportunities in chronic diseases","volume":"4","author":"Casc\u00e3o","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.cbi.2025.111412_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fphar.2018.00104","article-title":"A mechanistic overview of triptolide and celastrol, natural products from Tripterygium wilfordii Hook F","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111412_bib19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13020-021-00525-z","article-title":"Therapeutic potential of triptolide in autoimmune diseases and strategies to reduce its toxicity","volume":"16","author":"Cheng","year":"2021","journal-title":"Chin. Med."},{"key":"10.1016\/j.cbi.2025.111412_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1024955","article-title":"The therapeutic potential of triptolide and celastrol in neurological diseases","volume":"13","author":"Cui","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111412_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114705","article-title":"A comprehensive review on celastrol, triptolide and triptonide: insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes","volume":"162","author":"Song","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2025.111412_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.neuron.2019.07.030","article-title":"Agonist selectivity and ion permeation in the \u03b13\u03b24 ganglionic nicotinic receptor","volume":"104","author":"Gharpure","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.cbi.2025.111412_bib23","doi-asserted-by":"crossref","unstructured":"T. Ali, R. Bashir, I. Jan, K.I. Andrabi, G.N. Bader, Unravelling therapeutic potential and nano formulation approaches of farnesol, a bioactive sesquiterpene, Adv. Tradition. Med. (2024). in press.","DOI":"10.1007\/s13596-024-00768-9"},{"key":"10.1016\/j.cbi.2025.111412_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13020-021-00525-z","article-title":"Therapeutic potential of triptolide in autoimmune diseases and strategies to reduce its toxicity","volume":"16","author":"Cheng","year":"2021","journal-title":"Chin. Med."},{"key":"10.1016\/j.cbi.2025.111412_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.846746","article-title":"Applications and mechanisms of Tripterygium wilfordii Hook. F. And its preparations in kidney diseases","volume":"13","author":"Tong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111412_bib26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpha.2022.12.002","article-title":"Celastrol targeting Nedd4 reduces Nrf2-mediated oxidative stress in astrocytes after ischemic stroke","volume":"13","author":"Hong","year":"2023","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.cbi.2025.111412_bib27","doi-asserted-by":"crossref","first-page":"35381","DOI":"10.1074\/jbc.M109.051532","article-title":"Characterization of celastrol to inhibit hsp90 and cdc37 interaction","volume":"284","author":"Zhang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111412_bib28","doi-asserted-by":"crossref","first-page":"815","DOI":"10.14336\/AD.2021.1115","article-title":"Neuroprotective effects of celastrol in neurodegenerative diseases-unscramble its major mechanisms of action and targets","volume":"13","author":"Liu","year":"2022","journal-title":"Aging Dis"},{"key":"10.1016\/j.cbi.2025.111412_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26154700","article-title":"The therapeutic potential of celastrol in central nervous system disorders: highlights from in vitro and in vivo approaches","volume":"26","author":"Schiavone","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2025.111412_bib30","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.7150\/thno.57745","article-title":"Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives","volume":"11","author":"Gao","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.cbi.2025.111412_bib31","first-page":"622","article-title":"Targets and molecular mechanisms of triptolide in cancer therapy","volume":"26","author":"Meng","year":"2014","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.cbi.2025.111412_bib32","article-title":"Triptolide suppresses NF-\u03baB-Mediated inflammatory responses and activates expression of nrf2-mediated antioxidant genes to alleviate caerulein-induced acute pancreatitis","volume":"23","author":"Yang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2025.111412_bib33","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0092-8674(87)90705-7","article-title":"Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system","volume":"48","author":"Goldman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2025.111412_bib34","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","article-title":"Structural and functional diversity of native brain neuronal nicotinic receptors","volume":"78","author":"Gotti","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111412_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116263","article-title":"Functions and pharmacology of \u03b12\u03b22 nicotinic acetylcholine receptors; in and out of the shadow of \u03b14\u03b22 nicotinic acetylcholine receptors","volume":"225","author":"Papke","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111412_bib36","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/cne.902840212","article-title":"Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat","volume":"284","author":"Wada","year":"1989","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.cbi.2025.111412_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2012.08.012","article-title":"Nicotinic acetylcholine receptors: from basic science to therapeutics","volume":"137","author":"Hurst","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2025.111412_bib38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.ph.57.030195.002513","article-title":"Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons","volume":"57","author":"McGehee","year":"1995","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.cbi.2025.111412_bib39","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","article-title":"Structural and functional diversity of native brain neuronal nicotinic receptors","volume":"78","author":"Gotti","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111412_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1085\/jgp.111.2.257","article-title":"Activation of nicotinic acetylcholine receptors augments calcium channel-mediated exocytosis in rat pheochromocytoma (PC12) cells","volume":"111","author":"Harkins","year":"1998","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.cbi.2025.111412_bib41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/jnc.14966","article-title":"Expression of \u03b13\u03b22\u03b24 nicotinic acetylcholine receptors by rat adrenal chromaffin cells determined using novel conopeptide antagonists","volume":"154","author":"Hone","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2025.111412_bib42","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bcp.2017.12.008","article-title":"The wonderland of neuronal nicotinic acetylcholine receptors","volume":"151","author":"Bertrand","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111412_bib43","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1365-2982.2002.00363.x","article-title":"Ligand-gated ion channels in the enteric nervous system","volume":"14","author":"Galligan","year":"2002","journal-title":"Neuro Gastroenterol. Motil."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T14:11:20Z","timestamp":1740492680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":43,"alternative-id":["S0009279725000420"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111412","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subtype-selective effect and molecular regulation of celastrol and triptolide at human nicotinic acetylcholine receptors","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111412"}}